The STATIS trial compares, among people with no overt evidence of tuberculosis at study entry, empirical tuberculosis treatment to intensive investigation for tuberculosis among HIV-positive patients with a CD4 count under 100 cells/μL in Cambodia, Côte d’Ivoire, Uganda and Vietnam [26]. This evidence concerns the gene CD4 and tuberculosis.